631
Participants
Start Date
June 30, 2008
Primary Completion Date
December 31, 2009
Study Completion Date
June 30, 2011
Dapagliflozin
Tablets, Oral, 10 mg, Once Daily, 104 weeks
Dapagliflozin
Tablets, Oral, 5 mg, Once Daily, 104 weeks
Placebo
Tablets, Oral, 0 mg, Once Daily, 104 weeks
Local Institution, Lima Cercado
Local Institution, Lima
Local Institution, Camperdown
Local Institution, St Leonards
Local Institution, Copenhagen Nv
Local Institution, Woollongong
Local Institution, Hvidovre
Local Institution, Zárate
Local Institution, Gentofte Municipality
Local Institution, Córdoba
Local Institution, Launceston
Local Institution, Mar del Plata
Local Institution, Chieri
Winthrop University Hospital, Mineola
Local Institution, Df
Slocum-Dickson Medical Group, Pllc, New Hartford
Drexel University College Of Medicine, Philadelphia
Thomas Jefferson University, Philadelphia
The Strelitz Diabetes Center, Norfolk
Local Institution, Besançon
Local Institution, San Sebastian de Los
Low Country Internal Medicine Of Sc, Pa, Charleston
Palmetto Clinical Research, Summerville
Carolina Health Specialists, Myrtle Beach
Local Institution, Brest
Endocrine Research Solutions, Inc., Roswell
Panhandle Family Care Associates, Marianna
Genesis Clinical Research, Tampa
Local Institution, Durango
Local Institution, Padua
Local Institution, Celaya
Local Institution, Modena
Physician Research, Inc., Zanesville
Center For Thyroid Diseases And Endocrinology, Beachwood
Community Health Care Of Manchester, Akron
Local Institution, Guadalajara
Local Institution, Vizcaya
Local Institution, Siena
Aurora Advanced Healthcare, Milwaukee
Zablocki Veterans Affairs Medical Center, Milwaukee
Twin Cities Clinical Research, Brooklyn Center
Local Institution, Pisa
Kcva Medical Center Research Svc (151), Kansas City
Local Institution, Monterrey
Local Institution, Chieti Scalo
Va Nebraska-Western Iowa Health Care System (Nwihcs), Omaha
Univ Of Oklahoma Health Science Center, Oklahoma City
Research Institute Of Dallas, Dallas
Local Institution, Paris
Local Institution, Paris
Westbury Medical Clinic P.A., Houston
Endocrine Associates Of The Rockies, Denver
Vista Medical Research, Inc., Mesa
Local Institution, Poitiers
La Biomed At Harbor Ucla Med Ctr., Torrance
Diabetes Medical Center Of California, Northridge
Apex Research Of Riverside, Riverside
Valley Research, Fresno
Marin Endocrine Care & Research, Inc., Greenbrae
Office Of Richard Cherlin, Md, Los Gatos
Rogue Valley Clinical Research, Medford
Cedar Research Llc, Tacoma
Capital Clinical Research Center, Olympia
Local Institution, Singapore
Local Institution, Pune, Maharashtra
Local Institution, Indore
Local Institution, Bangalore
Local Institution, Chennai
University Of Medicine And Dentistry Of New Jersey, Voorhees Township
Local Institution, Buenos Aires
Local Institution, Buenos Aires
Local Institution, Capital Federal
Local Institution, Córdoba
Local Institution, Salta
Local Institution, Calgary
Local Institution, Winnipeg
Local Institution, Barrie
Local Institution, Thornhill
Local Institution, Toronto
Local Institution, Toronto
Local Institution, Gatineau
Local Institution, Laval
Local Institution, Sherbrooke
Local Institution, Regina
Local Institution, Pune
Local Institution, Bangalore
Local Institution, Rajasthan
Local Institution, Perugia
Local Institution, Roma
Local Institution, Df
Local Institution, Df
Local Institution, Arequipa
Local Institution, Lima
Local Institution, Caguas
Local Institution, San Juan
Local Institution, Barcelona
Lead Sponsor
Collaborators (1)
Bristol-Myers Squibb
INDUSTRY
AstraZeneca
INDUSTRY